Lumicell

Lumicell announced a leadership change on October 19, 2026. Lumicell promoted Chief Commercial Officer Marnie Curbow to Chief Executive Officer, effective immediately, to lead the company as it enters its next phase of commercial growth.

What changed

Marnie Curbow was named Chief Executive Officer. Marnie Curbow was promoted to Chief Executive Officer from her role as Chief Commercial Officer, and the announcement did not name a predecessor.

• Leader: Marnie Curbow
• Role: Chief Executive Officer
• Effective: Effective immediately
• Announcement date: October 19, 2026

Leadership background

Curbow joined Lumicell in October 2025 as Vice President of Sales and was promoted to Chief Commercial Officer, taking on sales, marketing, reimbursement, and clinical applications. Before Lumicell, she was GM and VP Sales Diagnostics for the Americas at Rhinomed, where she launched a novel diagnostic and secured a SPARK accelerator award from BARDA. The company said she has nearly two decades of experience spanning breast oncology, surgery, diagnostics, and therapeutics.

The mandate

Lumicell said Curbow will lead the company as it enters its next phase of commercial growth, and that the company will continue to focus on advancing adoption of pegulicianine fluorescence-guided surgery (pFGS), strengthening its commercial and clinical partnerships, expanding its investor base, and pursuing opportunities to expand the application of its technology across additional solid tumor indications.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Lumicell leadership announcement.